British pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...

Actress Brooke Shields shared a powerful thought on therapy. She believes looking at oneself honestly takes courage. Shields' journey shows...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

British drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

The Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...

ET Wealth presents an 8-quarter earnings assessment report of various sectors. The year-on-year net profit growth for 18 sectors is present...

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...

Originally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...

Mosquitoes are a persistent problem in India, but natural remedies offer a greener solution. Several indoor plants, including Lemon Balm, C...

A groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...

As therapy-related language becomes increasingly common, many people are questioning whether knowing mental health terminology automaticall...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

The study, which followed patients for over five years, found that those ⁠who received ⁠the regimen were nine times more likely to have lit...

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...

GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achievi...

Eli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This onc...